卵巢癌是妇女的第五大常见癌症,也是妇科恶性肿瘤的首要致死病因[1]。在美国2001年新确诊为卵巢癌的病例数为23400例,其中约有13900例将死于本病。高病死率与大多数本病患者早期缺乏典型症状及有效的普查手段有关[2,3],很多患者被确诊时已经是Ⅲ、Ⅳ期。尽管通过肿瘤细胞减灭术 Ovarian cancer is the fifth most common cancer in women and the leading cause of death in gynecologic malignancies [1]. In the United States in 2001 the newly diagnosed cases of ovarian cancer is 23,400 cases, of which about 13,900 cases will die of the disease. High CFR is associated with the early absence of typical symptoms and effective screening in most patients [2,3]. Many patients are already diagnosed with stage III and IV disease. Despite the cytoreductive surgery